LBRX LB Pharmaceuticals Inc
$39.64▲ +0.76%
Healthcare
Other
After hours
$39.64▲ +0.00%
Oct 27, 4:00 PM ET
Volume 236.3K
Avg Volume (10D) 428.0K
Key Metrics & Fundamentals
Market Cap
$1.28B
P/E Ratio
396.4
Div Yield
0.00%
52W Range
14.32 - 50.16
% vs 50 MA
-5.35%
% vs 200 MA
22.85%
RSI-14
53.1
MACD Histogram
+0.6800
Beta (1Y vs SPY)
0.53
Free Cash Flow
-$37.99M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$53.16M
COGS
–
Operating Exp
$53.92M
Operating Income
-$53.92M
EBIT
-$53.92M
Pretax Income
-$51.60M
Net Income
-$51.60M
EPS (Diluted)
-1.71
Price & Volume History
Loading chart…
Recent News
LB Pharmaceuticals to Participate in Upcoming Investor Events
GlobeNewswire · Oct 15, 2026 4:05 PM ET
LB Pharmaceuticals (LBRX) Stock Fair Value Rises As LB 102 Outlook Shifts
Simply Wall St. · Oct 10, 2026 9:15 PM ET
LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP Congress
GlobeNewswire · Oct 10, 2026 8:00 AM ET
LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 9, 2026 4:42 PM ET
Canaccord Genuity Initiates LB Pharmaceuticals at Buy With $65 Price Target
MT Newswires · Oct 9, 2026 5:20 AM ET
LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment
GlobeNewswire · Oct 6, 2026 8:00 AM ET
Guggenheim Initiates LB Pharmaceuticals at Buy With $80 Price Target
MT Newswires · Oct 6, 2026 6:00 AM ET
Roth Capital Downgrades LB Pharmaceuticals to Neutral From Buy, Price Target is $37
MT Newswires · Oct 5, 2026 8:59 AM ET
Needham Initiates LB Pharmaceuticals at Buy With $68 Price Target
MT Newswires · Oct 2, 2026 5:48 AM ET
LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer
GlobeNewswire · Sep 15, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See LBRX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.